Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Alamos Gold -- Ignore unavailable to you. Want to Upgrade?

To: geoffb_si who wrote (1880)	3/17/2002 8:22:38 PM
From: Al Collard	Respond to of 4470

Hi Geoff, Your in with ONC-t @$3.15 for 6,349 shares. Chart for Oncolytics Biotech, Inc: stockcharts.com[h,a]daclyiay[dc][pc20!b50][vc60][iLa12,26,9!Ll14]&pref=G From the chart of ONC we can see the stock tested and held the support of it's 20EMA last week on below average volume. The chart indicators are mixed showing no clear direction. Good luck with this pick, Al

To: geoffb_si who wrote (1880)	3/20/2002 6:46:57 PM
From: Al Collard	Respond to of 4470

ONC-t...in the news: Oncolytics Announces Webcast of Conference Call On REOLYSIN(R) Phase I Results newswire.ca

To: geoffb_si who wrote (1880)	3/21/2002 8:34:56 AM
From: Al Collard	Respond to of 4470

ONC-t...in the news: Oncolytics Biotech Inc. Announces REOLYSIN(R) Phase I Clinical Trial Results newswire.ca